Yang D - Search Results

1

ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway.

Fang Z, Wang Y, Wang Z, Xu M, Ren S, Yang D, Hong M, Xie W. Fang Z, et al. Among authors: yang d. Cancer Res. 2020 Oct 15;80(20):4399-4413. doi: 10.1158/0008-5472.CAN-20-1031. Epub 2020 Aug 21. Cancer Res. 2020. PMID: 32826278 Free PMC article.

2

lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.

Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S; Cancer Genome Atlas Research Network; Xie W, Yang D. Wang Z, et al. Among authors: yang d, yang b. Cancer Cell. 2018 Apr 9;33(4):706-720.e9. doi: 10.1016/j.ccell.2018.03.006. Epub 2018 Apr 2. Cancer Cell. 2018. PMID: 29622465 Free PMC article.

3

Sex-Dimorphic and Sex Hormone-Dependent Role of Steroid Sulfatase in Adipose Inflammation and Energy Homeostasis.

Bi Y, Jiang M, Guo W, Guan X, Xu M, Ren S, Yang D, Gaikwad NW, Selcer KW, Xie W. Bi Y, et al. Among authors: yang d. Endocrinology. 2018 Sep 1;159(9):3365-3377. doi: 10.1210/en.2018-00531. Endocrinology. 2018. PMID: 30060148 Free PMC article.

4

Systematic identification of non-coding pharmacogenomic landscape in cancer.

Wang Y, Wang Z, Xu J, Li J, Li S, Zhang M, Yang D. Wang Y, et al. Among authors: yang d. Nat Commun. 2018 Aug 9;9(1):3192. doi: 10.1038/s41467-018-05495-9. Nat Commun. 2018. PMID: 30093685 Free PMC article.

5

Pregnane X receptor activation potentiates ritonavir hepatotoxicity.

Shehu AI, Lu J, Wang P, Zhu J, Wang Y, Yang D, McMahon D, Xie W, Gonzalez FJ, Ma X. Shehu AI, et al. Among authors: yang d. J Clin Invest. 2019 Apr 30;129(7):2898-2903. doi: 10.1172/JCI128274. J Clin Invest. 2019. PMID: 31039134 Free PMC article.

6

Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.

Yan J, Tung HC, Li S, Niu Y, Garbacz WG, Lu P, Bi Y, Li Y, He J, Xu M, Ren S, Monga SP, Schwabe RF, Yang D, Xie W. Yan J, et al. Among authors: yang d. Gastroenterology. 2019 Sep;157(3):793-806.e14. doi: 10.1053/j.gastro.2019.05.066. Epub 2019 Jun 3. Gastroenterology. 2019. PMID: 31170413 Free PMC article.

7

Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer.

Kalscheuer S, Khanna V, Kim H, Li S, Sachdev D, DeCarlo A, Yang D, Panyam J. Kalscheuer S, et al. Among authors: yang d. Sci Rep. 2019 Aug 28;9(1):12492. doi: 10.1038/s41598-019-48993-6. Sci Rep. 2019. PMID: 31462656 Free PMC article.

8

KRCC1: A potential therapeutic target in ovarian cancer.

Dwivedi SKD, Shameer K, Dey A, Mustafi SB, Xiong X, Bhattacharya U, Neizer-Ashun F, Rao G, Wang Y, Ivan C, Yang D, Dudley JT, Xu C, Wren JD, Mukherjee P, Bhattacharya R. Dwivedi SKD, et al. Among authors: yang d. FASEB J. 2020 Feb;34(2):2287-2300. doi: 10.1096/fj.201902259R. Epub 2019 Dec 23. FASEB J. 2020. PMID: 31908025 Free PMC article.

9

Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance.

Wang Y, Fang Z, Hong M, Yang D, Xie W. Wang Y, et al. Among authors: yang d. Acta Pharm Sin B. 2020 Jan;10(1):105-112. doi: 10.1016/j.apsb.2019.09.011. Epub 2019 Oct 19. Acta Pharm Sin B. 2020. PMID: 31993309 Free PMC article. Review.

10

Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.

Wu Z, Li S, Tang X, Wang Y, Guo W, Cao G, Chen K, Zhang M, Guan M, Yang D. Wu Z, et al. Among authors: yang d. Theranostics. 2020 Mar 4;10(9):3939-3951. doi: 10.7150/thno.39341. eCollection 2020. Theranostics. 2020. PMID: 32226530 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22,492 results

Search Page